Cardiovascular & Hemostasis Research
400+ validated RUO ELISA and chromogenic assays for cardiac markers, coagulation factors, thrombosis, vascular biology, and lipid metabolism. 16+ species — from rodent MI models to large animal cardiology. KRISHZYME™ chromogenic assays EP Pharmacopoeia-compliant.
Eight Research Areas in Cardiovascular Science
KRISHZYME™ — Chromogenic Coagulation Enzyme Assays
Chromogenic activity assays — not ELISA. They measure coagulation serine protease enzymatic activity (IU/ml), not protein antigen concentration. The KBBA04 Factor Xa kit is EP Pharmacopoeia-compliant for heparin potency characterisation. For Research & Industry Use Only.
Activity Measurement at the Coagulation Cascade Convergence Point
A standard ELISA measures protein antigen concentration — it cannot distinguish active from inhibited enzyme. A chromogenic assay measures functional activity: residual Factor Xa or Thrombin cleaves a peptide-pNA substrate, releasing para-nitroaniline detected at 405 nm. Heparin potency is expressed as IU/ml Anti-Factor Xa or Anti-IIa activity — a regulatory requirement the chromogenic format fulfils and a protein ELISA cannot substitute for.
The KBBA04 working range (0.075–0.30 IU/ml) uses AT-III-mediated inhibition of Bovine Factor Xa; the Factor IIa assay similarly differentiates LMWH from UFH (UFH inhibits both Xa and IIa; LMWH predominantly Xa). Individual factor antigen ELISA (Factor II, V, VII, VIII, IX, X, XI, XII) measure protein levels at the same pathway steps — both assay types are complementary in coagulation research.
View All KRISHZYME™ Assays ›KBBA04 Protocol Summary
- 1AT-III + Sample (50 µl each)Incubate 37°C, 1 min. Heparin drives FXa inhibition rate.
- 2Bovine Factor Xa (100 µl)Incubate 37°C, exactly 2 min. Residual FXa inversely proportional to heparin.
- 3Chromogenic Substrate (100 µl)Incubate 37°C, 4 min. FXa cleaves substrate → pNA release.
- 4Acetic Acid stop → Read 405 nmParallel-line analysis → IU/ml Anti-Xa activity.
Flagship Biomarkers — Species Coverage & Research Context
Krishgen's highest-volume cardiovascular ELISA. Click any panel for research context, marker distinctions, and full species availability. All RUO.
cTnI vs cTnT — Structural Distinction and Research Applications
Both cTnI and cTnT are structural components of the cardiac troponin-tropomyosin complex. cTnI is encoded by a cardiac-specific gene with no equivalent in adult skeletal muscle — the most cardiac-specific of all isoforms. cTnT has a cardiac-specific C-terminus distinguishable from skeletal isoforms. In ischemia research, both are released from injured cardiomyocytes at 1–3 hours. cTnI is generally preferred for rodent cardiotoxicity models; cTnT has a longer research history in large animal cardiology (Equine, Bovine, Dog). Krishgen's 10-species panel enables direct translational comparison across rodent MI models and large animal studies.
cTnI — 10 species
Absolute cardiac specificity • Preferred for rodent models • No skeletal isoform in humans
cTnT — 5 species
Cardiac-specific C-terminus • Human, Mouse, Rat, Dog, Equine • Large animal cardiology
Species Availability
| Species | cTnI | cTnT |
|---|---|---|
| Human | ✓ | ✓ |
| Mouse | ✓ | ✓ |
| Rat | ✓ | ✓ |
| Rabbit | ✓ | — |
| Dog | ✓ | ✓ |
| Cat | ✓ | — |
| Equine | ✓ | ✓ |
| Bovine | ✓ | — |
| Porcine | ✓ | — |
| Monkey | ✓ | — |
BNP vs NT-proBNP — Same Prohormone, Different Research Utility
ProBNP cleavage yields two fragments in equimolar amounts. BNP (active, 32 aa, half-life ~20 min) reflects acute hemodynamic load in real time but is unstable in stored samples. NT-proBNP (inactive, 76 aa, half-life ~60–120 min) is renally cleared, far more stable, and preferred for batched or longitudinal research designs. Neither is more "accurate" — they measure different time windows of the same biological event.
The atrial equivalent ANP is released from atrial cardiomyocytes under stretch — it responds earlier and more sensitively to volume changes than BNP. NT-proANP is its stable inactive surrogate available for Human and Mouse research.
BNP
Active • Half-life ~20 min • Acute load • Fresh sample processing
NT-proBNP
Inactive • Half-life ~60–120 min • Stable • Batch processing
ANP
Atrial origin • Earlier than BNP • Volume-sensitive
NT-proANP
Stable atrial surrogate • Human & Mouse
Species Availability
| Species | BNP | NT-proBNP | ANP | NT-proANP |
|---|---|---|---|---|
| Human | ✓ | ✓ | ✓ | ✓ |
| Mouse | ✓ | ✓ | ✓ | — |
| Rat | ✓ | ✓ | ✓ | — |
| Dog | ✓ | ✓ | — | — |
| Cat | ✓ | — | — | — |
| Equine | ✓ | — | — | — |
| Porcine | ✓ | — | — | — |
Upstream Substrate & Downstream Degradation Product
Fibrinogen (Factor I) is the liver-synthesised plasma glycoprotein cleaved by thrombin to form fibrin — the structural backbone of the clot. It is also an acute-phase reactant, rising in infection and inflammation. Fibrinogen ELISA are available for 9 species including Bovine, Equine, Porcine, Dog, and Sheep — making it one of Krishgen's broadest-coverage hemostasis markers for large animal and veterinary cardiovascular research.
D-Dimer is the fibrin degradation product released when plasmin cleaves cross-linked fibrin — a simultaneous marker of clot formation and fibrinolytic activity. Elevated D-Dimer in research models indicates ongoing coagulation, as seen in thrombosis, DIC, and sepsis coagulopathy studies. Available in Human, Mouse, Rat, Rabbit.
Fibrinogen — 9 species
Upstream clot substrate • Acute-phase reactant • Plasma matrix • Large animal coverage
D-Dimer — 4 species
Downstream fibrin degradation • Active coagulation & fibrinolysis • Thrombosis & DIC models
Species Availability
| Species | Fibrinogen | D-Dimer |
|---|---|---|
| Human | ✓ | ✓ |
| Mouse | ✓ | ✓ |
| Rat | ✓ | ✓ |
| Rabbit | ✓ | ✓ |
| Bovine | ✓ | — |
| Equine | ✓ | — |
| Porcine | ✓ | — |
| Dog | ✓ | — |
| Sheep | ✓ | — |
Individual Factor Antigen ELISA — Protein Level Complement to KRISHZYME™ Activity Assays
The PT (extrinsic) pathway runs: Tissue Factor → FVIIa → FXa (with the common pathway). The aPTT (intrinsic) pathway runs: contact activation → FXIIa → FXIa → FIXa/FVIIIa → FXa. Individual factor antigen ELISA measure protein concentration (ng/ml) at each node — distinct from the KRISHZYME™ chromogenic assays that measure functional activity (IU/ml). A sample with normal antigen levels but inhibited activity (e.g. due to heparin or inhibitory antibodies) requires both assay types to fully characterise. Used in haemophilia research, factor deficiency models, and coagulation pathway biology.
PT Pathway
Factor II, V, VII, X • Extrinsic + common • Human, Mouse, Rat
aPTT Pathway
Factor VIII, IX, XI, XII • Intrinsic + contact • Human, Mouse (selected Rat)
Factor × Species
| Factor | Pathway | Hu | Mo | Rat |
|---|---|---|---|---|
| Factor II | PT / Common | ✓ | ✓ | ✓ |
| Factor V | PT / Common | ✓ | ✓ | — |
| Factor VII | PT / Extrinsic | ✓ | ✓ | ✓ |
| Factor X | PT / Common | ✓ | ✓ | ✓ |
| Factor VIII | aPTT / Intrinsic | ✓ | ✓ | ✓ |
| Factor IX | aPTT / Intrinsic | ✓ | ✓ | — |
| Factor XI | aPTT / Intrinsic | ✓ | ✓ | — |
| Factor XII | aPTT / Contact | ✓ | ✓ | — |
12 Species — One of the Broadest CRP Panels in the RUO Space
CRP is a liver-synthesised acute-phase pentameric protein produced in response to IL-6 from sites of tissue injury or inflammation. In cardiovascular research, high-sensitivity CRP (hsCRP) is used as a marker of low-grade vascular inflammation associated with atherosclerotic plaque instability and endothelial dysfunction. CRP naturally overlaps with Krishgen's immunology portfolio — the same kit serves both research communities.
CRP shows significant species variation: in mice, SAP (serum amyloid P) is the dominant acute-phase pentraxin and the CRP response is modest. In large animals — Bovine, Equine, Porcine, Dog — CRP is a genuine and robust acute-phase reactant with broad veterinary research utility. Standard and hsCRP formats are available for Human.
Standard CRP — 12 species
Acute inflammation • Large animal & veterinary research • Higher concentration range
hsCRP — Human
Low-grade vascular inflammation research • Atherosclerosis models • <0.1 mg/L sensitivity
Species Availability
| Species | CRP | hsCRP |
|---|---|---|
| Human | ✓ | ✓ |
| Mouse | ✓ | — |
| Rat | ✓ | — |
| Rabbit | ✓ | — |
| Bovine | ✓ | — |
| Equine | ✓ | — |
| Porcine | ✓ | — |
| Dog | ✓ | — |
| Cat | ✓ | — |
| Monkey | ✓ | — |
| Sheep | ✓ | — |
| Goat | ✓ | — |
Endothelial Adhesion Molecules — 10+ Species, Soluble Shed Forms in Plasma
Cell adhesion molecules are upregulated on activated endothelium (via NF-κB, IL-1β, TNF-α) and mediate the leukocyte adhesion cascade: E-Selectin and P-Selectin tether rolling leukocytes; ICAM-1 and VCAM-1 mediate firm arrest and transmigration. Soluble shed forms are measurable by ELISA in serum and plasma — giving a systemic readout of endothelial activation without tissue biopsy. PECAM-1 (CD31) marks endothelial junctions and is used in angiogenesis and barrier integrity research.
VCAM-1 and ICAM-1 are available across 10 species including large animals and primates — enabling translational studies from rodent atherosclerosis models to NHP vascular biology.
VCAM-1 & ICAM-1
10 species • Firm leukocyte adhesion • Atherosclerosis & endothelial activation
E- & P-Selectin
Rolling & tethering • E-Sel: endothelial • P-Sel: platelet + endothelial
Species Availability
| Species | VCAM-1 | ICAM-1 | E-Sel | P-Sel |
|---|---|---|---|---|
| Human | ✓ | ✓ | ✓ | ✓ |
| Mouse | ✓ | ✓ | ✓ | ✓ |
| Rat | ✓ | ✓ | ✓ | ✓ |
| Rabbit | ✓ | ✓ | — | ✓ |
| Bovine | ✓ | ✓ | — | — |
| Equine | ✓ | ✓ | — | — |
| Porcine | ✓ | ✓ | — | — |
| Dog | ✓ | ✓ | — | ✓ |
| Cat | — | ✓ | — | — |
| Monkey | ✓ | ✓ | — | — |
| Sheep | ✓ | — | — | — |
All Assays — Filter by Category
cTnI (10 species) and cTnT (Human, Mouse, Rat, Dog, Equine). Cardiac-specific structural proteins released from injured cardiomyocytes. Ischemia, cardiotoxicity, and large animal cardiology research.
FABP3 (30–60 min release; Human, Mouse, Rat), Myoglobin (1–4 h; Human, Mouse, Rat), CK-MB (3–4 h; Human, Rat). Earlier kinetics than troponin — used alongside it in serial panel studies.
Both from ventricular cardiomyocytes under wall stress. BNP: active, half-life ~20 min, reflects acute load. NT-proBNP: stable, half-life ~60–120 min, preferred for batched samples. Human, Mouse, Rat, Dog (both); Cat, Equine, Porcine (BNP only).
ANP from atrial cardiomyocytes — rises earlier than BNP under volume overload. NT-proANP is the stable inactive surrogate. ANP: Human, Mouse, Rat. NT-proANP: Human, Mouse.
Chromogenic activity assay — not ELISA. Measures UFH potency as IU/ml Anti-Xa activity via AT-III-mediated FXa inhibition at 405 nm. EP Pharmacopoeia-compliant. Range 0.075–0.30 IU/ml. 200 tests.
Chromogenic anti-IIa activity assay. Differentiates LMWH from UFH (UFH inhibits both IIa and Xa; LMWH predominantly Xa). EP Pharmacopoeia-compliant for heparin characterisation research.
Protein concentration ELISA (ng/ml) for PT factors (II, V, VII, X) and aPTT factors (VIII, IX, XI, XII). Complements chromogenic activity assays. Human, Mouse, Rat. Haemophilia, factor deficiency, and coagulation pathway research.
Fibrinogen (upstream substrate, 9 species including Bovine, Equine, Porcine, Dog, Sheep) and D-Dimer (downstream degradation product, Human, Mouse, Rat, Rabbit). Together they bracket clot formation and fibrinolytic resolution.
vWF (platelet adhesion; Human, Mouse, Bovine, Equine), PAI-1 (fibrinolysis inhibitor; Human, Mouse, Rat), tPA (fibrinolysis activator; Human, Mouse), Protein C (anticoagulant; Human, Mouse). PAI-1/tPA balance determines fibrinolytic capacity.
Vascular and intercellular adhesion molecules mediating firm leukocyte adhesion in atherosclerosis research. Both available in Human, Mouse, Rat, Rabbit, Bovine, Equine, Porcine, Dog, Monkey, and Sheep. Soluble shed forms in serum/plasma.
E-Selectin (endothelial; Human, Mouse, Rat), P-Selectin (platelet + endothelial; Human, Mouse, Rat, Rabbit, Dog), PECAM-1/CD31 (endothelial junctions & angiogenesis; Human, Mouse, Rat). Soluble forms measurable in plasma.
VEGF-A (angiogenesis, 9 species), Endothelin-1 (most potent vasoconstrictor; Human, Mouse, Rat), Angiotensin II (RAAS effector; Human, Mouse, Rat). Covering angiogenesis, vasoconstriction, and hypertension pathway research.
GDF-15 (stress cytokine; Human, Mouse), Galectin-3 (macrophage-driven fibrosis; Human, Mouse, Rat), sST2 (IL-33 decoy receptor, blunts cardioprotection under stress; Human, Mouse). Novel markers in heart failure and fibrosis research models.
MMP-2 and MMP-9 drive extracellular matrix degradation post-ischemia; TIMP-1 and TIMP-2 are their endogenous inhibitors. The MMP/TIMP ratio determines ventricular dilation in heart failure research models. Human, Mouse, Rat.
FABP3 (ultra-early cardiac marker and FA shuttle; Human, Mouse, Rat), FABP4 (adipose-driven CV risk; Human, Mouse, Rat), ApoB/ApoA-I/Lp(a)/oxLDL/PCSK9 (lipoprotein risk biology; Human, selected in Mouse). Covers intracellular FA transport through to circulating lipoprotein risk factors.
Beclin-1 (initiation), LC3B-II (autophagosome marker, flux readout), p62 (inverse flux indicator), PINK1/Parkin (mitophagy of depolarised mitochondria), BNIP3 (hypoxia-induced mitophagy). Validated in cell lysates and tissue homogenates. Human, Mouse, Rat.
CRP across 12 species (Human through Goat). hsCRP for Human (low-grade vascular inflammation research). CRP overlaps the immunology portfolio — same kit, dual research utility. Standard and high-sensitivity formats.
PTX3 (locally produced at plaque — complements liver-derived CRP), MPO (neutrophil activation, oxidises LDL; Human, Mouse, Rat), Resistin and MCP-1 (adipokine and monocyte recruitment; Human, Mouse, Rat). All validated in serum and plasma.
Detailed Product Tables — Expand by Category
All kits For Research & Industry Use Only. Expand each panel for assay detail.
Cardiac Injury & Natriuretic Peptide ELISA
Troponin • BNP • NT-proBNP • ANP • CK-MB • Myoglobin • FABP3 • Human through Monkey • RUO +Quantitative sandwich ELISA. Validated in serum and plasma. Species-specific antibody pairs — do not cross-species. All RUO.
| Target | Species | Sensitivity | Matrix | Link |
|---|---|---|---|---|
| cTnI | Human • Mouse • Rat • Rabbit • Dog • Cat • Equine • Bovine • Porcine • Monkey | <0.01–0.02 ng/ml | Serum, Plasma | View |
| cTnT | Human • Mouse • Rat • Dog • Equine | <0.01–0.02 ng/ml | Serum, Plasma | View |
| BNP | Human • Mouse • Rat • Dog • Cat • Equine • Porcine | <1–2 pg/ml | Serum, Plasma, Urine | View |
| NT-proBNP | Human • Mouse • Rat • Dog | <1 pg/ml | Serum, Plasma | View |
| ANP | Human • Mouse • Rat | <1 pg/ml | Plasma (EDTA) | View |
| NT-proANP | Human • Mouse | <1 pg/ml | Serum, Plasma | View |
| CK-MB | Human • Rat | <0.1 ng/ml | Serum, Plasma | View |
| Myoglobin | Human • Mouse • Rat | <0.5 ng/ml | Serum, Plasma, Urine | View |
| FABP3 (H-FABP) | Human • Mouse • Rat | <0.1 ng/ml | Serum, Plasma | View |
| GDF-15 | Human • Mouse | <1 pg/ml | Serum, Plasma | View |
| Galectin-3 | Human • Mouse • Rat | <0.5 ng/ml | Serum, Plasma | View |
KRISHZYME™ Chromogenic Coagulation Assays
Factor Xa • Factor IIa • AT-III • Protein C • Plasminogen • EP Pharmacopoeia • RUO +Chromogenic enzyme activity assays — measure functional activity (IU/ml), not antigen concentration (ng/ml). EP Pharmacopoeia-compliant for heparin characterisation. All For Research & Industry Use Only.
| Assay | REF | Principle | Range | Tests | EP | Link |
|---|---|---|---|---|---|---|
| Factor Xa (Anti-Xa / UFH Potency) | KBBA04 | AT-III + Bovine FXa + pNA substrate • 405 nm | 0.075–0.30 IU/ml | 200 | Yes | View |
| Factor IIa / Thrombin (Anti-IIa) | KBBA02 | AT-III + Thrombin + pNA substrate • 405 nm | 0.05–0.30 IU/ml | 200 | Yes | View |
| Antithrombin III Functional Activity | KBBA05 | Heparin-amplified FXa inhibition | 60–140 % activity | 200 | Yes | View |
| Factor VIIa Activity | KBBA07 | TF-dependent chromogenic | Custom | 100 | — | View |
| Protein C Functional Activity | KBBA08 | Thrombomodulin-activated PC + substrate | 60–140 % activity | 100 | — | View |
| Plasminogen / tPA Fibrinolytic Activity | KBBA09 | SK-activated plasminogen + substrate | Custom | 100 | — | View |
PT/aPTT Factor ELISA • Thrombosis & Hemostasis — Fibrinogen, D-Dimer, vWF, PAI-1
Human • Mouse • Rat • Rabbit • Bovine • Equine • Porcine • Dog • Sheep • RUO +Factor antigen ELISA (ng/ml) complement the KRISHZYME™ activity assays. Fibrinogen spans 9 species. All RUO.
| Target | Pathway / Category | Species | Matrix | Link |
|---|---|---|---|---|
| Factor II (Prothrombin) | PT / Common | Human • Mouse • Rat | Plasma | View |
| Factor V | PT / Common | Human • Mouse | Plasma | View |
| Factor VII | PT / Extrinsic | Human • Mouse • Rat | Plasma | View |
| Factor VIII | aPTT / Intrinsic | Human • Mouse • Rat | Plasma | View |
| Factor IX | aPTT / Intrinsic | Human • Mouse | Plasma | View |
| Factor X | PT / Common | Human • Mouse • Rat | Plasma | View |
| Factor XI | aPTT / Intrinsic | Human • Mouse | Plasma | View |
| Factor XII | aPTT / Contact | Human • Mouse | Plasma | View |
| Fibrinogen | Clot formation | Human • Mouse • Rat • Rabbit • Bovine • Equine • Porcine • Dog • Sheep | Plasma | View |
| D-Dimer | Fibrinolysis | Human • Mouse • Rat • Rabbit | Plasma, Serum | View |
| vWF Antigen | Platelet adhesion | Human • Mouse • Bovine • Equine | Plasma | View |
| PAI-1 | Fibrinolysis inhibitor | Human • Mouse • Rat | Plasma, Cell SN | View |
| tPA | Fibrinolysis activator | Human • Mouse | Plasma | View |
| Protein C (Antigen) | Anticoagulant | Human • Mouse | Plasma | View |
| Thrombomodulin | Anticoagulant | Human • Mouse • Rat | Plasma, Urine | View |
CRP / hsCRP & Adhesion Molecules — VCAM-1, ICAM-1, E-Selectin, P-Selectin (Multi-Species)
Up to 12 species • Human • Mouse • Rat • Bovine • Equine • Porcine • Dog • Cat • Monkey • Sheep • RUO +CRP across 12 species; VCAM-1 and ICAM-1 across 10 species. All sandwich ELISA in serum and plasma. All RUO.
| Target | Species | Sensitivity | Link |
|---|---|---|---|
| CRP | Human • Mouse • Rat • Rabbit • Bovine • Equine • Porcine • Dog • Cat • Monkey • Sheep • Goat | Varies | View |
| hsCRP | Human | <0.1 mg/L | View |
| VCAM-1 | Human • Mouse • Rat • Rabbit • Bovine • Equine • Porcine • Dog • Monkey • Sheep | <0.1 ng/ml | View |
| ICAM-1 | Human • Mouse • Rat • Rabbit • Bovine • Equine • Porcine • Dog • Cat • Monkey | <0.1 ng/ml | View |
| E-Selectin (CD62E) | Human • Mouse • Rat | <0.1 ng/ml | View |
| P-Selectin (CD62P) | Human • Mouse • Rat • Rabbit • Dog | <0.1 ng/ml | View |
| PECAM-1 (CD31) | Human • Mouse • Rat | <0.1 ng/ml | View |
| Pentraxin-3 (PTX3) | Human • Mouse • Rat | <0.1 ng/ml | View |
| MPO | Human • Mouse • Rat | <0.1 ng/ml | View |
From the Krishgen Lab Blog
View all posts ›Related Research Areas
Building a Cardiovascular Research Panel?
Our technical team can configure matched cardiac marker panels across species, advise on KRISHZYME™ chromogenic protocols, and source any cardiovascular RUO assay target.
